← Back to Search

Special Pre-Surgery Diet for Head and Neck Cancer

N/A
Waitlist Available
Led By Carissa M. Thomas, MD, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of moderate (Stage B) or severe (Stage C) malnutrition, based on the patient-generated subjective global assessment (PG-SGA)
Ability to consent for themselves
Must not have
Cirrhosis
Stage III or higher Chronic Kidney Disease (CKD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline - 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a special diet before surgery can improve outcomes for people with head and neck cancer.

Who is the study for?
Adults diagnosed with head and neck cancer preparing for major surgery, who are moderately or severely malnourished. They must understand English and be able to consent. Excluded are those under 18, pregnant, with autoimmune disorders requiring medication, chronic immunosuppression, advanced kidney disease, cirrhosis, pancreatitis or allergies to fish oil.
What is being tested?
The study is testing the effects of a nutritional drink called Nestlé Impact Advanced Recovery on the gut microbiome and surgical outcomes in patients undergoing major surgery for head & neck cancers.
What are the potential side effects?
While not explicitly stated here, potential side effects may include digestive discomfort or allergic reactions related to ingredients in the nutritional drink such as fish oil.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with moderate to severe malnutrition.
Select...
I can make my own medical decisions.
Select...
I have had major surgery involving tissue reconstruction.
Select...
I have head or neck cancer and will undergo major surgery.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with cirrhosis.
Select...
My kidney disease is at stage III or more advanced.
Select...
I cannot give consent for medical procedures by myself.
Select...
I am on medication for an autoimmune disorder.
Select...
I have pancreatitis.
Select...
I have leukemia.
Select...
I am under 18 years old.
Select...
I have a history of gastrointestinal disorders or surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline - 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Define changes in the gut microbiome in malnourished patients with head and neck cancer after a pre-operative nutrition intervention via analyses of stool samples.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nutrition intervention groupExperimental Treatment1 Intervention
Participants will receive Nestlé Impact Advanced Recovery Immunonutrition two times daily for 5 days leading up to the date of surgery. Nestlé Impact Advanced Recovery will be administered either orally or through a feeding tube.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,753 Total Patients Enrolled
Carissa M. Thomas, MD, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Nestlé Impact Advanced Recovery Clinical Trial Eligibility Overview. Trial Name: NCT05061316 — N/A
Head and Neck Cancers Research Study Groups: Nutrition intervention group
Head and Neck Cancers Clinical Trial 2023: Nestlé Impact Advanced Recovery Highlights & Side Effects. Trial Name: NCT05061316 — N/A
Nestlé Impact Advanced Recovery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05061316 — N/A
~5 spots leftby Nov 2025